Nobivac® Intra-Trac®3 ADT
Manufacturer: Merck Animal Health
This treatment applies to Dogs.
Canine Adenovirus Type 2-parainfluenza-bordetella Bronchiseptica Vaccine
Modified Live Virus and Avirulent Live Culture
(Advanced Delivery Technology)
For Intranasal Use In Dogs Only
Nobivac® Intra-Trac® 3 ADT vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough.
A proven 1-year intranasal vaccine that provides triple protection against the agents implicated in the cause of tracheobronchitis (ìcanine coughî) with unique Advanced Delivery Technology (ADT).
Features and benefits
Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2.
ADT eliminates the possibility of accidental injection
Offers the superior benefits of intranasal administration
Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
Requires only single-nostril administrationólow dose of 0.5 mL
This item is NON-RETURNABLE and NON-REFUNDABLE.